4D Molecular Therapeutics Statistics
Total Valuation
FDMT has a market cap or net worth of $311.51 million. The enterprise value is -$82.45 million.
Important Dates
The last earnings date was Monday, August 11, 2025, before market open.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
FDMT has 46.70 million shares outstanding. The number of shares has increased by 17.47% in one year.
| Current Share Class | 46.70M |
| Shares Outstanding | 46.70M |
| Shares Change (YoY) | +17.47% |
| Shares Change (QoQ) | +0.33% |
| Owned by Insiders (%) | 3.87% |
| Owned by Institutions (%) | 74.06% |
| Float | 35.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9,439.56 |
| Forward PS | 137.70 |
| PB Ratio | 0.74 |
| P/TBV Ratio | 0.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.75, with a Debt / Equity ratio of 0.05.
| Current Ratio | 8.75 |
| Quick Ratio | 8.46 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -38.87% and return on invested capital (ROIC) is -26.33%.
| Return on Equity (ROE) | -38.87% |
| Return on Assets (ROA) | -25.18% |
| Return on Invested Capital (ROIC) | -26.33% |
| Return on Capital Employed (ROCE) | -50.19% |
| Revenue Per Employee | $145 |
| Profits Per Employee | -$864,070 |
| Employee Count | 227 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.53% in the last 52 weeks. The beta is 2.82, so FDMT's price volatility has been higher than the market average.
| Beta (5Y) | 2.82 |
| 52-Week Price Change | -55.53% |
| 50-Day Moving Average | 4.55 |
| 200-Day Moving Average | 4.98 |
| Relative Strength Index (RSI) | 67.37 |
| Average Volume (20 Days) | 2,384,162 |
Short Selling Information
The latest short interest is 3.70 million, so 7.93% of the outstanding shares have been sold short.
| Short Interest | 3.70M |
| Short Previous Month | 3.62M |
| Short % of Shares Out | 7.93% |
| Short % of Float | 10.35% |
| Short Ratio (days to cover) | 9.34 |
Income Statement
In the last 12 months, FDMT had revenue of $33,000 and -$196.14 million in losses. Loss per share was -$3.52.
| Revenue | 33,000 |
| Gross Profit | -170.19M |
| Operating Income | -220.33M |
| Pretax Income | -109.89M |
| Net Income | -196.14M |
| EBITDA | -215.82M |
| EBIT | -220.33M |
| Loss Per Share | -$3.52 |
Full Income StatementBalance Sheet
The company has $293.23 million in cash and $23.08 million in debt, giving a net cash position of $393.95 million or $8.44 per share.
| Cash & Cash Equivalents | 293.23M |
| Total Debt | 23.08M |
| Net Cash | 393.95M |
| Net Cash Per Share | $8.44 |
| Equity (Book Value) | 420.89M |
| Book Value Per Share | 9.01 |
| Working Capital | 268.61M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$166.39 million and capital expenditures -$3.42 million, giving a free cash flow of -$169.81 million.
| Operating Cash Flow | -166.39M |
| Capital Expenditures | -3.42M |
| Free Cash Flow | -169.81M |
| FCF Per Share | -$3.64 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -667,654.55% |
| Pretax Margin | -594,375.76% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FDMT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.47% |
| Shareholder Yield | -17.47% |
| Earnings Yield | -62.97% |
| FCF Yield | -54.51% |
Analyst Forecast
The average price target for FDMT is $30.63, which is 359.22% higher than the current price. The consensus rating is "Buy".
| Price Target | $30.63 |
| Price Target Difference | 359.22% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 393.82% |
| EPS Growth Forecast (5Y) | 5.46% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FDMT has an Altman Z-Score of 1.83 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.83 |
| Piotroski F-Score | 1 |